Positioning Intelligence
Short Interest Intelligence
Reported short interest, days to cover, price reaction, sector pressure, squeeze risk, bearish conviction, and where positioning is fighting the tape.
Signal Design
Not just “high short interest”
We score the latest reported short position against its own history, then compare that crowding with days to cover, price movement since the prior report, and Sharemaestro trend context. The result is a research map, not a trade recommendation.
The aim is to show where positioning is crowded, confirmed, trapped, or unwinding, so the user can build a better shortlist before doing ticker-level work.
Squeeze Radar
crowding plus price pressureBearish Conviction
shorts being confirmedPositioning Divergence
shorts versus priceCovering Confirmation
bearish trade unwindingSector Short Pressure
where crowding clustersSetup Distribution
classification mixPositioning Map
short positioning versus price reactionRadar Table
Current Short-Interest Reads
| Stock | Setup | Score | Short interest | Change | Days cover | Price reaction | Trend |
|---|---|---|---|---|---|---|---|
| MNOVMediciNova Inc | Squeeze Pressure | 69 | 204.8K | +99.9% | 2.95 | +7.3% | Weak |
| HBNBHotel101 Global Holdings Corp. Class A Ordinary Shares | Bearish Conviction | 69 | 12.1K | +8.6% | 1.94 | -4.1% | Weak |
| PEPGPepGen Ltd | Squeeze Pressure | 69 | 4.0M | +3.8% | 5.80 | +15.6% | Weak |
| COFSChoiceOne Financial Services Inc | Squeeze Pressure | 69 | 330.7K | +22.5% | 2.19 | +1.9% | Constructive |
| NABLN-Able Inc | Squeeze Pressure | 69 | 4.3M | +14.8% | 1.62 | +10.3% | Weak |
| NOWServiceNow Inc | Squeeze Pressure | 69 | 62.1M | +4.4% | 2.43 | -3.7% | Improving |
| MSLESatellos Bioscience Inc. Common Stock | Squeeze Pressure | 69 | 83.5K | +18.9% | 1.74 | +23.1% | Mixed |
| NOCNorthrop Grumman Corporation | Bearish Conviction | 69 | 2.4M | +10.1% | 2.00 | -9.1% | Weak |
| UVSPUnivest Corporation Pennsylvania | Squeeze Pressure | 69 | 722.6K | +12.8% | 2.18 | +4.3% | Constructive |
| DLHCDLH Holdings Corp | Bearish Conviction | 69 | 76.0K | +97.4% | 1.00 | -4.5% | Weak |
| IOSPInnospec Inc | Squeeze Pressure | 69 | 487.1K | +19.3% | 1.97 | -4.6% | Constructive |
| NKTRNektar Therapeutics | Squeeze Pressure | 69 | 6.9M | +39.5% | 4.47 | +7.2% | Mixed |
| SENEBSeneca Foods Corp B | Squeeze Pressure | 69 | 781 | +18.5% | 2.42 | -6.3% | Constructive |
| ACMAecom Technology Corporation | Bearish Conviction | 69 | 9.0M | +41.1% | 3.90 | +1.3% | Weak |
| CNTBConnect Biopharma Holdings Ltd | Bearish Conviction | 69 | 1.3M | +25.1% | 2.12 | +3.3% | Weak |
| CRBPCorbus Pharmaceuticals Holding | Bearish Conviction | 69 | 1.9M | +23.1% | 3.40 | +6.7% | Weak |
| EVCMEverCommerce Inc | Bearish Conviction | 69 | 1.8M | +19.5% | 10.35 | +2.0% | Weak |
| JRVRJames River Group Holdings Ltd | Bearish Conviction | 69 | 1.6M | +27.8% | 2.99 | +6.0% | Weak |
| PAVMPAVmed Inc | Bearish Conviction | 69 | 33.6K | +299.7% | 1.00 | +1.0% | Weak |
| PHIPLDT Inc ADR | Bearish Conviction | 69 | 199.8K | +35.4% | 1.00 | +3.0% | Weak |
| SMRTSmartRent Inc | Bearish Conviction | 69 | 6.4M | +130.9% | 1.72 | +7.0% | Weak |
| SPRBSpruce Biosciences, Inc. Common Stock | Bearish Conviction | 69 | 359.4K | +36.9% | 3.15 | +6.2% | Weak |
| APCARKO Petroleum Corp. | Bearish Conviction | 69 | 787.7K | +145.5% | 2.20 | -9.4% | Mixed |
| WAFDPWaFd, Inc. | Squeeze Pressure | 69 | 74.8K | +1879.7% | 1.26 | +2.6% | Mixed |
| BMBLBumble Inc | Squeeze Pressure | 69 | 13.5M | +18.8% | 2.12 | +11.8% | Weak |
| ATECAlphatec Holdings Inc | Squeeze Pressure | 69 | 14.6M | +18.3% | 3.60 | +12.3% | Weak |
| ATHEAlterity Therapeutics Ltd | Covering Rally | 69 | 39.0K | -27.8% | 1.17 | +14.5% | Constructive |
| SRADSportradar Group AG | Squeeze Pressure | 69 | 11.3M | +10.2% | 5.59 | -7.1% | Improving |
| AXONAxon Enterprise Inc. | Squeeze Pressure | 69 | 4.1M | +6.2% | 3.22 | +5.2% | Improving |
| CULPCulp, Inc. Common Stock | Squeeze Pressure | 69 | 31.2K | +12.9% | 1.00 | -0.3% | Improving |
Short interest is delayed, reported twice monthly, and shown for educational research only. It does not prove buyer or seller intent, and it is not financial advice.